Please ensure Javascript is enabled for purposes of website accessibility

Chris Preston

Vice President of Content and Chief Analyst of Cabot Stock of the Week

Chris Preston is Cabot Wealth Network’s Vice President of Content and Chief Analyst of Cabot Stock of the Week.

Chris joined Cabot in 2015, where he previously served as staff analyst, web editor, and Chief Analyst of Cabot Wealth Daily, our free investment advisory, which in 2019 was named “Best Financial/Investing Newsletter or Ezine” at the SIPA (Specialized Information Publishers Association) Awards, with Chris at the helm.

Prior to joining Cabot, Chris was an analyst and assistant managing editor with Wyatt Investment Research. He has been an investment analyst for more than a decade and a professional writer/editor for nearly 20 years, picking up multiple writing awards along the way. His bylines have appeared in Forbes, The Money Show, Time Magazine, U.S. News and World Report and

Chris lives in Vermont with his wife, two young kids and their golden retriever, Scout. He occasionally sleeps.

From this author
MercadoLibre stock is both the Amazon and eBay of Latin America - only with more upside. And it’s already crushing most U.S. stocks.
Reliable dividend stocks may seem obvious and boring. But if you buy them and hang on, they can make your future. These five stand out now.
The best six months strategy from November-April can be profitable. But here are two market timing indicators that are more precise.
“Resilient” is not a word that would have described stocks in 2022, but through the first quarter of 2023, that’s precisely what they’ve been in the face of a bank meltdown, more interest rate hikes and still-high inflation. It bodes well for the back half of the year when perhaps some – maybe all? – of those worries subside. In the meantime, we have to say goodbye to a couple underperforming stocks today, while adding a growth play that lies outside U.S. borders. It’s a Mexican consumer products stock that takes advantage of Mexico’s cheap manufacturing costs – and the stock is up 22% year to date!

Banking crisis fears have subsided, and while the fallout from Silicon Valley Bank, Silvergate and Signature Bank simultaneously going under is sure to be felt in the market for weeks and months to come, it’s also not looking like 2008 out there, at least not at the moment. Still, we could use some more safety in the portfolio, and today we add it in the form of a large-cap healthcare giant that’s a reliable dividend payer, boasts one of the industry’s best drug pipelines, and has been outperforming the market for years. It’s a favorite of Cabot Dividend Investor Chief Analyst Tom Hutchinson, who recently upgraded the stock to Buy.
Artificial intelligence is one of the fastest-growing markets in the world, and artificial intelligence stocks have benefitted.
All Quiet on the Western Front is an ironically titled movie about war that won several awards at last night’s Oscars. It could loosely describe the last few days in the U.S. stock market too, as the collapse of three major banks (and counting?) has abruptly sent stocks tumbling back down into bear market territory and brought anxiety, uncertainty and volatility back to the forefront. So today, we’re selling our one bank stock, plus one other shaky growth stock, but making room for a cookie-cutter retail company that’s on solid ground. It’s a longtime favorite of Cabot Growth Investor Chief Analyst Mike Cintolo.
The unemployment-stock market correlation is a picture-perfect inverse. What does that mean with the jobless rate back at pre-Covid lows?
Stocks rebounded nicely last week, giving hope that the 2023 stock market may be far more resilient than the 2022 market – which could eventually get us out of this bear market malaise. That makes it a good time to buy one of the blue-chip tech stocks that were infamously beaten into submission by last year’s indiscriminate selloff in all things technology. Fortunately, Tyler Laundon is recommending just such a stock – a name this is familiar to all, and yet is embarking on some exciting new ventures that the general public might not be fully aware of. Today, we add this mega-cap technology giant to the Stock of the Week portfolio.
Term preferred stocks and baby bonds offer some of the best fixed-rate bonds to buy on today’s market. And right now, four of them stand out.
Stocks continued to retreat last week, ensuring a down February after a very promising January. Still, the latest pullback has been fairly modest, with the 200-day moving average now acting as a floor instead of a ceiling, as it did for most of 2022. With the market in a state of flux, we’re adding another dividend stock today – a household name that used to be part of the Stock of the Week portfolio before we sold it late last summer. That looks like a mistake, as the stock has risen 11% since, and seems to be gathering more steam of late. It’s a longtime recommendation of Cabot Dividend Investor Chief Analyst Tom Hutchinson.

In comparing Coke vs. Pepsi stock, neither soda giant will blow you away. But over the long haul, both are uncannily reliable. Which is best?
McDonald’s isn’t the dominant growth story it was. But McDonald’s stock continues its steady performance - and a breakout may be coming.
The market has hit its first real rough patch of 2023, but so far the damage has been fairly limited. Still, it makes sense to add some protection, so today we’re adding a value stock that’s been one of the better performers in Bruce Kaser’s Cabot Undervalued Stocks Advisor portfolio for the past six months – but still has plenty of upside. Also, with the Stock of the Week portfolio at max capacity, we are parting ways with several positions to clear out some room for better opportunities in the coming weeks.
AMZN stock and GOOG stock are two musts for any portfolio. But which tech behemoth is better positioned for future growth?
Worried that the next bear market is long overdue? This 100-year stock market chart may help provide some encouraging perspective.
An improving stock market brings our Stock of the Week portfolio to capacity, 20 stocks, with today’s addition of a fallen growth stock whose name you will almost certainly recognize. It’s a company whose business was hampered more than most during Covid, but has now returned to pre-pandemic levels – and is on track to resume its prior growth trajectory in the years ahead. And the stock is finally playing catch-up. It’s a new addition from Cabot Growth Investor Chief Analyst Mike Cintolo.
They are two of the most recognizable names out there, and good stocks, but which is the better buy? Let’s break down Apple vs. Amazon stock.
Cabot Analysts have once again been included in the Money Show’s Top Picks Report, an annual report from some of the brightest analysts on Wall Street. Here’s a selection.
The stock-market picture continues to improve, and it’s possible the current rally is more than yet another head fake; it could be the start of a new bull market. While we’re not there yet, there’s reason for optimism. So today, we take another big swing by adding a fast-emerging electric vehicle maker that has struggled since its IPO last June but is showing signs of life lately. It’s a recent recommendation from Cabot Explorer Chief Analyst Carl Delfeld.

With the market in the midst of a correction it’s important to know how to identify undervalued stocks and not just “cheap” stocks.
Water, the most abundant resource on the planet, is becoming increasingly scarce in certain parts. These water stocks and ETFs are thriving.
Bitcoin has been one of the best investments over the last five years, but is bitcoin a good long-term investment? Let’s examine.
It’s been an encouraging start to the year for stocks, but another Fed rate hike – and whatever choice words Jerome Powell has to say – could throw the brakes on the rally this week, at least temporarily. To prepare for another potential pullback, today we’re adding some protection in the form of a high-yield dividend payer from the healthcare industry. It’s a stock with some real momentum – up 18% in the last five weeks – but still trades at about half of where it was a year ago. And Tom Hutchinson just upgraded it to Buy in Cabot Dividend Investor.
The market has been resilient through the first few weeks of 2023, giving hope that a much better year lies ahead for investors. Potential potholes abound (earnings season is underway, another Fed rate hike next week, a possible recession looming, etc.), but for now, there’s reason for optimism. With that in mind, we take another big swing today by adding a mid-cap technology stock that was just recommended by Cabot Early Opportunities Chief Analyst Tyler Laundon.

The FAANGs are the biggest growth stocks on the market today. What are the companies most likely to be the next FAANG stocks?
The new year is off to a good start, with stocks across the board showing true signs of momentum and very few still in the doldrums. Several of our Stock of the Week positions, in fact, are hitting either all-time highs or 52-week highs! But just in case this is yet another bear market rally, today we’re covering our bases by adding a big, well-known bank trading at bargain prices. It’s a longtime recommendation from Cabot Undervalued Stocks Advisor Chief Analyst Bruce Kaser – and one that Bruce says has more than 60% upside.
Investing in a business development company is a high-risk, high-reward proposition for income investors. But you can mitigate risks.
2023 has started with a bang, pushing a couple stocks in our portfolio to new all-time highs! Both of those high fliers have benefitted greatly from the return to relative normalcy in the wake of Covid, so today we add another stock that stands to get a direct bump from China’s reopening – or at least the loosening of its draconian “zero Covid” policies. The company was a pre-pandemic favorite of Cabot Top Ten Trader Chief Analyst Mike Cintolo and looks like a great value pick now as its business picks up in earnest. So, he’s recommending it again.
Lululemon is the fastest growing sports apparel company. Is it a better buy than Nike? Let’s break down Nike stock vs. Lululemon stock.